Fig. 3From: The risk of dyspnea in patients treated with third-generation P2Y12 inhibitors compared with clopidogrel: a meta-analysis of randomized controlled trialsForest plot of risk ratios for the incidence of dyspnea of ticagrelor vs clopidogrel stratified by follow-up durationBack to article page